GLAXOSMITHKLINE PLC 13D and 13G filings for Wave Life Sciences Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 4:32 pm Purchase |
2024-09-30 | 13G | Wave Life Sciences Ltd. WVE |
GLAXOSMITHKLINE PLC | 16,775,691 11.200% |
16,775,691 (New Position) |
Filing |
| 2024-02-06 5:07 pm Purchase |
2023-12-31 | 13G | Wave Life Sciences Ltd. WVE |
GLAXOSMITHKLINE PLC | 13,983,761 11.500% |
3,300,000 (+30.89%) |
Filing |
| 2023-01-30 4:37 pm Purchase |
2023-01-23 | 13G | Wave Life Sciences Ltd. WVE |
GLAXOSMITHKLINE PLC | 10,683,761 10.950% |
10,683,761 (New Position) |
Filing |